Ruth Rodríguez‐Barrueco

Author

Also Known As

R Rodriguez-Barrueco, R. Rodriguez Barrueco, R. Rodríguez-Barrueco, Rodriguez-Barrueco, Ruth, Rodríguez-Barrueco, Ruth, Ruth Barrueco, Ruth Rodriguez Barrueco, Ruth Rodriguez-Barrueco, Ruth Rodriguez Barrueco, Ruth Rodriguez‐Barrueco

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

Columbia University Icahn School of Medicine at Mount Sinai Cancer Genetics (United States)Universitat de Barcelona Centro de Investigación Biomédica en Red de Cáncer

About

Ruth Rodríguez‐Barrueco is an author at Columbia University specializing in medicine, cell biology, and cancer biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	2.3K
2	Engineering	2	2	198
3	Natural Sciences	2	2	100
4	Health Sciences	1	1	17
5	Biochemistry	1	1	24

Ruth Rodríguez‐Barrueco

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway William A. Freed-Pastor, Hideaki Mizuno, Xi Zhao, Cell MedicineMevalonate PathwayMammary GlandBreast CancerTumor Suppressor	2012	850
Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells Josep Domingo‐Domenech, Samuel J. Vidal, Verónica Rodríguez-Bravo, Cancer Cell Lineage PlasticityUrologyOncologyAcquired Docetaxel ResistanceMedicine	2012	432
Cross-Cohort Analysis Identifies a TEAD4–MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma Presha Rajbhandari, Gonzalo López, Claudia Capdevila, Cancer Discovery GeneticsPathologyDisease Gene IdentificationMycnamp NeuroblastomasCancer Biology	2018	187
A Targetable GATA2-IGF2 Axis Confers Aggressiveness in Lethal Prostate Cancer Samuel J. Vidal, Verónica Rodríguez-Bravo, S. Aidan Quinn, Cancer Cell UrologyMedicineCancer BiologyProstatic DiseaseLethal Prostate Cancer	2015	153
Inhibition of the autocrine IL-6–JAK2–STAT3–calprotectin axis as targeted therapy for HR<sup>−</sup>/HER2<sup>+</sup>breast cancers Ruth Rodríguez‐Barrueco, Jiyang Yu, Laura Saucedo-Cuevas, Genes & Development Autocrine Il-6–jak2–stat3–calprotectin AxisBreast OncologySignaling PathwayMedicineImmunology	2015	118
Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer Núria Eritja, Bo‐Juen Chen, Ruth Rodríguez‐Barrueco, Autophagy MitophagyEngineeringKinase InhibitorsCancer BiologyTumor Biology	2017	104
Integration of Genomic Data Enables Selective Discovery of Breast Cancer Drivers Félix Sanchez-Garcia, Patricia Villagrasa, Junji Matsui, Cell Functional GenomicsEngineeringTranslational BioinformaticsBiomedical Data IntegrationMedicine	2014	94
miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy Ruth Rodríguez‐Barrueco, Erin A. Nekritz, François Bertucci, Genes & Development Breast OncologyCancer BiologyMammary Gland DevelopmentTumor BiologyCancer Cell Biology	2017	90
Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells Haiying Cheng, Zhenfeng Zhang, Ruth Rodríguez‐Barrueco, Oncotarget	2015	89
The <i>miR-424(322)/503</i> cluster orchestrates remodeling of the epithelium in the involuting mammary gland David Llobet‐Navàs, Ruth Rodríguez‐Barrueco, Verónica Castro, Genes & Development Mammary Gland DevelopmentTranscriptional RegulationTissue DevelopmentCell SignalingMolecular Signaling	2014	76

Page 1